Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of chronic conditions
3.2.1.2 Rising investments for novel cancer therapies
3.2.1.3 Advancements in diagnostic imaging
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of therapies and diagnostic procedures
3.2.2.2 Stringent government regulations
3.3 Growth potential analysis
3.4 Reimbursement scenario
3.5 Regulatory landscape
3.6 Technological landscape
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Therapeutic
5.3 Diagnostics
5.3.1 PET
5.3.2 SPECT
5.3.3 Other diagnostic tests
Chapter 6 Market Estimates and Forecast, By Radioisotopes, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Technetium 99m
6.3 Gallium 68
6.4 Lodine I
6.5 Fluorine 18
6.6 Copper 64
6.7 Radium 223
6.8 Zirconium 89
6.9 Other radioisotopes
Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Cancer
7.2.1 Breast cancer
7.2.2 Prostate cancer
7.2.3 Lung cancer
7.2.4 Other cancer types
7.3 Neurology
7.4 Cardiology
7.5 Other applications
Chapter 8 Market Estimates and Forecast, By Source, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Cyclotron
8.3 Nuclear reactors
Chapter 9 Market Estimates and Forecast, By End Use, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 Hospitals
9.3 Diagnostic imaging centers
9.4 Research and academic institutes
Chapter 10 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Netherlands
10.3.7 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Argentina
10.5.4 Rest of Latin America
10.6 Middle East and Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 UAE
10.6.4 Rest of Middle East and Africa
Chapter 11 Company Profiles
11.1 Bayer AG
11.2 Bracco
11.3 Cardinal Health Inc.
11.4 Coquí Radiopharmaceuticals Corp
11.5 Curium Pharma
11.6 Eli Lilly and Company
11.7 General Electric Company
11.8 IRE ELiT
11.9 Iso-Tex Diagnostics, Inc
11.10 Jubilant Pharmova Limited
11.11 Lantheus
11.12 Novartis AG
11.13 SHINE Technologies, LLC
11.14 Telix Pharmaceuticals Limited
